CODAC Health Recovery and Wellness Inc CODAC at Speedway

CODAC Health Recovery and Wellness Inc CODAC at Speedway

Services:
Pharmacotherapies
• Naltrexone (oral)
• Buprenorphine without naloxone
• Medications for Hepatitis C treatment
• Disulfiram
• Acamprosate (Campral�)
• Non-nicotine smoking/tobacco cessation
• Medication for mental disorders
• Buprenorphine with naloxone
• Naltrexone (extended-release, injectable)
• Nicotine replacement
• Clonidine

Language Services

• Sign language services for the deaf and hard of hearing
• Spanish

Type of Care

• Substance use treatment
• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Age Groups Accepted

• Young Adults
• Adults

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Medicare
• Private health insurance
• Federal military insurance (e.g., TRICARE)
• Medicaid

Ancillary Services

• Integrated primary care services
• Suicide prevention services
• Mental health services
• Case management service

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Special Programs/Groups Offered

• Adult men
• Adult women
• Clients with co-occurring mental and substance use disorders
• Clients who have experienced trauma

Medical Services

• Hepatitis A (HAV) vaccination
• Hepatitis B (HBV) vaccination

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• No formal relationship with prescribing entity
• In-network prescribing entity

Recovery Support Services

• Assistance with obtaining social services
• Recovery coach
• Mentoring/peer support
• Employment counseling or training

Gender Accepted

• Male
• Female

Assessment/Pre-treatment

• Screening for mental disorders
• Complete medical history/physical exam
• Screening for substance use
• Comprehensive substance use assessment
• Comprehensive mental health assessment
• Screening for tobacco use

Transitional Services

• Naloxone and overdose education
• Discharge Planning

Facility Smoking Policy

• Smoking not permitted

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Education and Counseling Services

• Family counseling
• Hepatitis education, counseling, or support
• HIV or AIDS education, counseling, or support
• Substance use disorder education
• Group counseling
• Health education services other than HIV/AIDS or hepatitis
• Marital/couples counseling
• Smoking/vaping/tobacco cessation counseling
• Individual counseling
• Vocational training or educational support (for example, high school coursework, GED preparation, etc.)

Facility Vaping Policy

• Vaping not permitted

License/Certification/Accreditation

• State department of health
• Commission on Accreditation of Rehabilitation Facilities (CARF)

Treatment Approaches

• Matrix Model
• Brief intervention
• Relapse prevention
• Motivational interviewing
• Telemedicine/telehealth therapy
• Cognitive behavioral therapy
• Anger management
• Contingency management/motivational incentives
• Trauma-related counseling
• Substance use disorder counseling

Type of Opioid Treatment

• Prescribes buprenorphine
• Accepts clients using MAT but prescribed elsewhere
• Prescribes naltrexone

Testing

• Testing for Hepatitis C (HCV)
• Testing for Hepatitis B (HBV)
• Drug and alcohol oral fluid testing
• STD testing
• TB screening
• HIV testing
• Metabolic syndrome monitoring
• Drug or alcohol urine screening
• Breathalyzer or blood alcohol testing

External Opioid Medications Source

• Other contracted prescribing entity
• In-network prescribing entity
• No formal relationship with prescribing entity